Abstract: The present invention relates to a nanoemulsion of resveratrol-phospholipid complex, method for preparing the same and applications thereof. The nanoemulsion comprises: 1 part by weight of resveratrol, 2˜30 parts by weight of phospholipid, and 30˜490 parts by weight of an aqueous solution of polyol with the polyol concentration being 30˜99 percent by weight. The method comprises the steps of: a resveratrol-phospholipid complex being prepared, then the complex being dispersed into the aqueous solution of polyol to form a dispersion, and a nanoemulsion with particle size less than 200 nm being formed by homogenization of the dispersion with a high pressure homogenizer or Microfluidizer homogenizer. The nanoemulsion is miscible with water at any ratio, has high stability and high bioavailability, and thus can be widely used for preparation of cosmetics, pharmaceuticals or healthcare products.

Abstract: The present invention relates to a nanoemulsion of resveratrol-phospholipid complex, method for preparing the same and applications thereof. The nanoemulsion comprises: 1 part by weight of resveratrol, 2˜30 parts by weight of phospholipid, and 30˜490 parts by weight of an aqueous solution of polyol with the polyol concentration being 30˜99 percent by weight. The method comprises the steps of: a resveratrol-phospholipid complex being prepared, then the complex being dispersed into the aqueous solution of polyol to form a dispersion, and a nanoemulsion with particle size less than 200 nm being formed by homogenization of the dispersion with a high pressure homogenizer or Microfluidizer homogenizer. The nanoemulsion is miscible with water at any ratio, has high stability and high bioavailability, and thus can be widely used for preparation of cosmetics, pharmaceuticals or healthcare products.

Abstract: The invention relates to the method for preparation of orally administrated insulin oil formulation comprising: dissolving an amount of insulin in an acidic aqueous buffer(A); adding A to liquid surfactant, the HLB value of which is between 10 and 20, with agitation to form a homogeneous solution(B); adding B to an oil, the HLB value of which is between 0 and 10, with agitation to form oil formulation. This invention has a simple process with low cost. After orally administrated, the formulation prepared with the process of the invention can resist the gastrointestinal degradation by digestive enzymes, and is easily absorbed for hypoglycemic effect.

Abstract: The invention relates to the method for preparation of orally administrated insulin oil formulation comprising: dissolving an amount of insulin in an acidic aqueous buffer (A); adding A to liquid surfactant, the HLB value of which is between 10 and 20, with agitation to form a homogeneous solution (B); adding B to an oil, the HLB value of which is between 0 and 10, with agitation to form oil formulation. This invention has a simple process with low cost. After orally administrated, the formulation prepared with the process of the invention can resist the gastrointestinal degradation by digestive enzymes, and is easily absorbed for hypoglycemic effect.